FIGURE

Fig. 2

ID
ZDB-FIG-190723-184
Publication
Grimm et al., 2019 - Yap1 promotes sprouting and proliferation of lymphatic progenitors downstream of Vegfc in the zebrafish trunk
Other Figures
All Figure Page
Back to All Figure Page
Fig. 2

Yap1 acts cell autonomously to control trunk lymphangiogenesis in zebrafish.

( A) Overall morphology of sibling (left) and MZ yap1ncv101-/- mutant (right) at 5 dpf. Arrowheads indicate mild craniofacial defects and absent swim bladder. Scale bar 200 μm. ( B–C) Trunk vasculature of sibling and MZ yap1ncv101-/- mutant embryos at 5 dpf. Veins and lymphatics are displayed in white [ Tg(dab2b:EGFP)], erythrocytes show normal blood flow in red [ Tg(gata1:DsRed)]. Asterisks mark absent lymphatic vessels. ( C) Trunk vasculature of sibling and MZ yap1mw48-/- mutant at 6 dpf. Vascular nuclei are marked in green [ Tg(fli1a:nEGFP)], venous and lymphatic vessels in white [ Tg(−5.2lyve1b:DsRed)]. Asterisks indicate absent lymphatic vessels. Scale bars: 50 μm in B and C. ( D) Percentage of TD fragments formed per somite, scored across six somites in total for siblings and MZ yap1ncv101-/-mutants at 5 dpf (sibling: 100% ± 0, n = 23; MZ yap1ncv101-/-: 49% ± 7.33, n = 22; p,0.0001). ( E) Quantification of the total number of LECs across 6 somites at 6 dpf (sibling: 37 ± 1.91, n = 11; MZ yap1mw48-/-: 8 ± 3.79; p<0.0001). ( F) Schematic showing the cell transplantation technique. Blastomere cells are transplanted from donor (EGFP) into host (mCherry) embryos. This results in a chimeric host embryo (right) with randomly located, transplanted EC grafts. ( G) Representative images of host chimeric trunk vessels at 5 dpf. Wildtype (wt) donor ECs contribute to all vascular EC types, while MZ yap1ncv101-/- mutant ECs show reduced propensity to contribute to lymphatic structures. Asterisk marks missing TD. Scale bars: 50 μm. ( H) Graft sizes analysed for vascular grafts. Numbers within bars represent the number of embryos scored for each graft size. ( I) Percentage of embryos with EC grafts contributing to arterial (wt into wt: 96% ± 4; MZ yap1ncv101-/- into wt: 100% ± 0; p=0.31, not significant (ns)), venous (wt into wt: 91% ± 6; MZ yap1ncv101-/- into wt: 67% ± 10; p=0.04 (*)) and lymphatic vessels (wt into wt: 43% ± 10; MZ yap1ncv101-/- into wt: 8% ± 6; p=0.005 (**)). Wildtype into wildtype total number of EC grafts: n = 23; MZ yap1ncv101-/- mutant into wildtype total number of EC grafts: n = 24. Dorsal aorta (DA); Posterior Cardinal Vein (PCV); Thoracic Duct (TD); Intersegmental Lymphatic vessel (ISLV), Dorsal Longitudinal Lymphatic vessel (DLLV).


Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife